Meeting Overview - The 10th meeting of the 11th Supervisory Board of Beihai Guofa Chuanshan Biological Co., Ltd. was held on July 31, 2025, with all three supervisors participating in the voting [2][5] - The meeting was legally convened and chaired by Mr. Lü Qiujun [2] Audit Institution Appointment - The Supervisory Board approved the proposal to appoint Shanghai Shuhui Accounting Firm (Special General Partnership) as the special audit institution for the company's 2025 A-share issuance to specific targets [3][8] - The appointment does not require submission to the shareholders' meeting for approval [4] Audit Institution Details - Shanghai Shuhui Accounting Firm was established in January 1981 and has undergone several transformations, with its current form established in December 2013 [8] - The firm has provided audit services to 72 listed companies in 2024, with a total audit revenue of 0.81 billion yuan [9] - The firm has a total revenue of 0.683 billion yuan in 2024, with 0.204 billion yuan from securities business [9][10] Voting Results - The proposal received unanimous support from the Supervisory Board, with 3 votes in favor and no opposition or abstentions, representing 100% of the valid voting rights [5] Board Meeting Overview - The 17th meeting of the 11th Board of Directors was also held on July 31, 2025, with all 9 directors participating [21] - The Board approved the proposal to appoint the same audit institution for the 2025 A-share issuance, with a unanimous vote of 9 in favor [32][33] Financing Guarantee - The company agreed to provide a guarantee for its wholly-owned subsidiary, Beihai Guofa Pharmaceutical Co., Ltd., for a loan of 20 million yuan from China Postal Savings Bank [29][34] - The loan term is set for 3 years, and the company will not charge any guarantee fees [34][41] - The total amount of external guarantees before this loan was 0 yuan, and the new guarantee represents 2.58% of the company's audited net assets [44]
北海国发川山生物股份有限公司第十一届监事会第十次会议决议公告